Clofibrate
Catalog No. A10229
Clofibrate可增加肝外脂蛋白脂肪酶(LL)的活性,从而增加脂蛋白甘油三酸酯脂解作用。 乳糜微粒降解,VLDL转化为LDL,LDL转化为HDL。
Catalog Num | A10229 |
---|---|
M. Wt | 242.7 |
Formula | C12H15ClO3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 637-07-0 |
Synonyms | |
SMILES | CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl |
Clofibrate可增加肝外脂蛋白脂肪酶(LL)的活性,从而增加脂蛋白甘油三酸酯脂解作用。 乳糜微粒降解,VLDL转化为LDL,LDL转化为HDL。
In vitro | DMSO | 7 mg/mL (28.84 mM) | |
Water | Insoluble | ||
Ethanol | 5 mg/mL (20.6 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 41.2 mL | 206.02 mL | 412.03 mL |
0.5 mM | 8.24 mL | 41.2 mL | 82.41 mL |
1 mM | 4.12 mL | 20.6 mL | 41.2 mL |
5 mM | 0.82 mL | 4.12 mL | 8.24 mL |
*The above data is based on the productmolecular weight 242.7. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.